Selank

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro, MW ~751.89 g/mol) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a structural analogue of the immunomodulatory peptide tuftsin with an added Pro-Gly-Pro sequence for stability. Approved in Russia as an anxiolytic and nootropic nasal spray, it crosses the blood-brain barrier to enhance GABAergic neurotransmission, modulate monoamine systems, and regulate neuropeptide Y signaling. A 2008 study of 62 patients with GAD showed Selank comparable to medazepam for anxiety reduction but with no sedation, cognitive impairment, or dependence risk. Half-life is approximately 2-10 minutes.

Nootropic / AnxiolyticNeurotransmitter ModulationCognitive Enhancement
Vendors
17 vendors
Sizes
5 mg – 30 mg
Intake
Injections · Nasal Sprays

Typical dose

250-500mcg daily 1-2 times daily

1-2 times daily

Route

Intranasal spray

Can be used morning or evening. Unlike benzodiazepines, selank typically does not cause drowsiness.

Cycle

2-8 weeks Typical duration

Typical duration

Storage

2-8°C Refrigerated

Follow vendor guidance

Marketplace

Vendor listings

17 offers for Selank

VendorPriceRatingShippingCOAAction

Biologix Labs

United StatesFast

$24.98

$31.99

$5.00/mg

21.9%
No reviews

2 Days

United States, Canada

None

HLX LABS

United StatesFast

$24.99

$5.00/mg

No reviews

2–5 days

United States

None

Amino Club

United StatesFast

$29.95

$3.00/mg

No reviews

1–4 days

United States

None

Certa Peptides

RomaniaFast

$29.99

$6.00/mg

No reviews

1–4 days

Switzerland, United Kingdom +29

None

idunpeptides

United States

$29.99

$3.00/mg

No reviews

3–7 days

United States, United Kingdom +1

None

Bionova Peptides

United StatesFast

$30.00

$60.00

$6.00/mg

50%
No reviews

1–3 days

United States

None

Trulab Peptides

United StatesFast

$31.00

$6.20/mg

No reviews

2–5 days

Worldwide

None

LA Peptides

United StatesFast

$39.99

$4.00/mg

No reviews

2–5 days

United States

None

What the research reports

Reported research benefits.

Outcomes described across the published literature and ongoing study, not promised results. Read each as research context, not a personal guarantee.

01

Anxiety reduction

02

Cognitive enhancement

03

Stress relief

04

Focus improvement

Dosage and protocol

How it is typically studied.

Selank is an anxiolytic peptide developed in Russia, typically administered intranasally at 200-400mcg per day. It may reduce anxiety without sedation.

01 Route

Intranasal spray, Subcutaneous

02 Example range

200-300mcg

03 Frequency

1-2 times daily

04 Timing

Can be used morning or evening. Unlike benzodiazepines, selank typically does not cause drowsiness.

Educational reference only. Use clinician guidance for dosing decisions.

Evidence

What the studies actually show.

1

[Optimization of the treatment of anxiety disorders with selank].

Combined selank and phenazepam treatment reduced benzodiazepine side effects while maintaining anxiolytic efficacy.

2

Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia.

Selank showed anxiolytic effects similar to medazepam with additional antiasthenic effects.

3

A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders.

Selank demonstrated anxiolytic and nootropic effects comparable to phenazepam with improved tolerability.

4

Functional Connectomic Approach to Studying Selank and Semax Effects.

Selank and Semax alter resting-state functional connectivity in amygdala and prefrontal cortex regions.

Interactions

How it pairs with other peptides.

SEMAX Neutral · Well-documented

Neutral to mildly synergistic. Different neurological targets with no known negative interaction.

FAQ

Frequently asked questions.

Selank is a synthetic peptide developed in Russia combining a tuftsin fragment with additional amino acids, researched for its anxiolytic (anti-anxiety) and nootropic effects.